0
Article ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Sign in to save

Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia

International Journal of Molecular Sciences 2022 41 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count. Score: 45 ? 0–100 AI score estimating relevance to the microplastics field. Papers below 30 are filtered from public browse.
Giuseppe Sirago, Anna Picca, Anna Picca, Riccardo Calvani, Hélio José Coelho‐Júnior, Emanuele Marzetti

Summary

This review summarized how mTOR signaling regulates skeletal muscle maintenance and how dysregulation contributes to sarcopenia, the age-related loss of muscle mass and function. Intervention strategies targeting mTOR including exercise, caloric restriction, and plant extract supplementation show promise for slowing muscle decline in aging.

Body Systems

The mammalian target of rapamycin (mTOR) is a major regulator of skeletal myocyte viability. The signaling pathways triggered by mTOR vary according to the type of endogenous and exogenous factors (e.g., redox balance, nutrient availability, physical activity) as well as organismal age. Here, we provide an overview of mTOR signaling in skeletal muscle, with a special focus on the role played by mTOR in the development of sarcopenia. Intervention strategies targeting mTOR in sarcopenia (e.g., supplementation of plant extracts, hormones, inorganic ions, calorie restriction, and exercise) have also been discussed.

Sign in to start a discussion.

Share this paper